{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "regularMarketChangePercent": -1.8260894, "regularMarketPrice": 0.5645, "exchange": "ASE", "shortName": "AgeX Therapeutics, Inc.", "longName": "AgeX Therapeutics, Inc.", "messageBoardId": "finmb_529976464", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": -0.454, "fiftyDayAverage": 0.61494, "fiftyDayAverageChange": -0.050440013, "fiftyDayAverageChangePercent": -0.08202428, "twoHundredDayAverage": 0.622195, "twoHundredDayAverageChange": -0.05769503, "twoHundredDayAverageChangePercent": -0.09272821, "marketCap": 21870592, "priceToBook": -1.243392, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1683921900, "earningsTimestampStart": 1691492340, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.28, "sharesOutstanding": 37951300, "firstTradeDateMilliseconds": 1543501800000, "priceHint": 4, "regularMarketChange": -0.010500014, "regularMarketTime": 1684180063, "regularMarketDayHigh": 0.57105, "regularMarketDayRange": "0.56 - 0.57105", "regularMarketDayLow": 0.56, "regularMarketVolume": 5958, "regularMarketPreviousClose": 0.575, "bid": 0.561, "ask": 0.5775, "bidSize": 400, "askSize": 13, "fullExchangeName": "NYSE American", "financialCurrency": "USD", "regularMarketOpen": 0.56, "averageDailyVolume3Month": 15228, "averageDailyVolume10Day": 10170, "fiftyTwoWeekLowChange": 0.064499974, "fiftyTwoWeekLowChangePercent": 0.12899995, "fiftyTwoWeekRange": "0.5 - 0.9", "fiftyTwoWeekHighChange": -0.3355, "fiftyTwoWeekHighChangePercent": -0.3727778, "fiftyTwoWeekLow": 0.5, "fiftyTwoWeekHigh": 0.9, "marketState": "PRE", "displayName": "AgeX Therapeutics", "symbol": "AGE"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1101 Marina Village Parkway", "address2": "Suite 201", "city": "Alameda", "state": "CA", "zip": "94501", "country": "United States", "phone": "(510) 671-8370", "fax": "(510) 671-8619", "website": "https://www.agexinc.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as peripheral vascular disease and ischemic heart disease. Its lead small molecule drug-based therapeutic candidate for scarless wound repair in discovery is AGEX-iTR1547, a drug-based formulation; and lead biologic candidate for induced tissue regeneration is AGEX-iTR1550 (Renelon), a gene delivery technology. AgeX Therapeutics, Inc. has a research collaboration with the University of California at Irvine to develop cellular therapies to treat neurological disorders and diseases. The company was incorporated in 2017 and is based in Alameda, California.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Michael D. West Ph.D.", "age": 69, "title": "Founder, Pres, CEO & Director", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": {"raw": 562032, "fmt": "562.03k", "longFmt": "562,032"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Eun-Jae  Park CPA", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 295289, "fmt": "295.29k", "longFmt": "295,289"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nafees Naseer Malik M.D.", "age": 44, "title": "Chief Operating Officer", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 282272, "fmt": "282.27k", "longFmt": "282,272"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ivan  Labat", "title": "Chief Information Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Judith  Segall", "age": 69, "title": "Sec.", "yearBorn": 1953, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}